Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Clinical Pig Kidney Xenotransplantation: How Close Are We?

Cooper DKC, Hara H, Iwase H, Yamamoto T, Jagdale A, Kumar V, Mannon RB, Hanaway MJ, Anderson DJ, Eckhoff DE.

J Am Soc Nephrol. 2019 Dec 2. pii: ASN.2019070651. doi: 10.1681/ASN.2019070651. [Epub ahead of print]

PMID:
31792154
2.

Life-supporting Kidney Xenotransplantation From Genetically Engineered Pigs in Baboons: A Comparison of Two Immunosuppressive Regimens.

Yamamoto T, Hara H, Foote J, Wang L, Li Q, Klein EC, Schuurman HJ, Zhou H, Li J, Tector AJ, Zhang Z, Ezzelarab M, Lovingood R, Ayares D, Eckhoff DE, Cooper DKC, Iwase H.

Transplantation. 2019 Oct;103(10):2090-2104. doi: 10.1097/TP.0000000000002796.

PMID:
31283686
3.

HLA Class I-sensitized Renal Transplant Patients Have Antibody Binding to SLA Class I Epitopes.

Martens GR, Ladowski JM, Estrada J, Wang ZY, Reyes LM, Easlick J, Smith C, Butler JR, Sidner RA, Eckhoff DE, Tector M, Tector J.

Transplantation. 2019 Aug;103(8):1620-1629. doi: 10.1097/TP.0000000000002739.

PMID:
30951017
4.

Effect of Renal Diagnosis on Survival in Simultaneous Liver-Kidney Transplantation.

Cannon RM, Jones CM, Davis EG, Eckhoff DE.

J Am Coll Surg. 2019 Apr;228(4):536-544.e3. doi: 10.1016/j.jamcollsurg.2018.12.003. Epub 2018 Dec 23.

PMID:
30586642
5.

Ethnic and Age Disparities in Outcomes Among Liver Transplant Waitlist Candidates.

Mustian MN, Shelton BA, MacLennan PA, Reed RD, White JA, Eckhoff DE, Locke JE, Allman RM, Gray SH.

Transplantation. 2019 Jul;103(7):1425-1432. doi: 10.1097/TP.0000000000002523.

PMID:
30418427
6.

Data on B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy.

Yamamoto T, Li Q, Hara H, Wang L, Zhou H, Li J, Eckhoff DE, Tector AJ, Klein EC, Lovingood R, Ezzelarab M, Ayares D, Wang Y, Cooper DKC, Iwase H.

Data Brief. 2018 Sep 13;20:1965-1974. doi: 10.1016/j.dib.2018.08.213. eCollection 2018 Oct.

7.

What's hot, what's new: Report from the American Transplant Congress 2018.

Eckhoff DE, Fairchild RL, Abdi R.

Am J Transplant. 2018 Dec;18(12):2857-2868. doi: 10.1111/ajt.15130. Epub 2018 Oct 29.

8.

B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy.

Yamamoto T, Li Q, Hara H, Wang L, Zhou H, Li J, Eckhoff DE, Joseph Tector A, Klein EC, Lovingood R, Ezzelarab M, Ayares D, Wang Y, Cooper DKC, Iwase H.

Transpl Immunol. 2018 Dec;51:12-20. doi: 10.1016/j.trim.2018.08.005. Epub 2018 Aug 6.

9.

Xenoantigen Deletion and Chemical Immunosuppression Can Prolong Renal Xenograft Survival.

Adams AB, Kim SC, Martens GR, Ladowski JM, Estrada JL, Reyes LM, Breeden C, Stephenson A, Eckhoff DE, Tector M, Tector AJ.

Ann Surg. 2018 Oct;268(4):564-573. doi: 10.1097/SLA.0000000000002977.

10.

Two Cases and a Review of Graft-Versus-Host Disease and the Role of Hepatitis C Treatment in Liver Transplant Patients.

Advani SD, Nellore A, Hadjivassiliou G, Eckhoff DE, Salzman D, Lavie D, Pavlidakey P, Baddley JW.

Prog Transplant. 2018 Sep;28(3):267-270. doi: 10.1177/1526924818781558. Epub 2018 Jun 28.

PMID:
29954253
11.

Heavy Alcohol Use Among Deceased Donors Does Not Impact Recipient Outcomes After Liver Transplantation.

Arora SS, Chahal KS, Axley P, Eckhoff DE, Kuo YF, Satapathy SK, Wiesner R, Singal AK.

Transplantation. 2018 Nov;102(11):1864-1869. doi: 10.1097/TP.0000000000002230.

PMID:
29677070
12.

Examining the Biosynthesis and Xenoantigenicity of Class II Swine Leukocyte Antigen Proteins.

Ladowski JM, Martens GR, Reyes LM, Wang ZY, Eckhoff DE, Hauptfeld-Dolejsek V, Tector M, Tector AJ.

J Immunol. 2018 Apr 15;200(8):2957-2964. doi: 10.4049/jimmunol.1800022. Epub 2018 Mar 14.

13.

Current guidelines for chemoembolization for hepatocellular carcinoma: Room for improvement?

White JA, Gray SH, Li P, Simpson HN, McGuire BM, Eckhoff DE, Abdel Aal AMK, Saddekni S, Dubay DA.

Hepatol Commun. 2017 May 18;1(4):338-346. doi: 10.1002/hep4.1046. eCollection 2017 Jun.

14.

Swine Leukocyte Antigen Class II Is a Xenoantigen.

Ladowski JM, Reyes LM, Martens GR, Butler JR, Wang ZY, Eckhoff DE, Tector M, Tector AJ.

Transplantation. 2018 Feb;102(2):249-254. doi: 10.1097/TP.0000000000001924.

15.

Orthotopic liver transplantation changes the course of gastric antral vascular ectasia: a case series from a transplant center.

Allamneni C, Alkurdi B, Naseemuddin R, McGuire BM, Shoreibah MG, Eckhoff DE, Peter S.

Eur J Gastroenterol Hepatol. 2017 Aug;29(8):973-976. doi: 10.1097/MEG.0000000000000908.

PMID:
28520574
16.

Humoral Reactivity of Renal Transplant-Waitlisted Patients to Cells From GGTA1/CMAH/B4GalNT2, and SLA Class I Knockout Pigs.

Martens GR, Reyes LM, Li P, Butler JR, Ladowski JM, Estrada JL, Sidner RA, Eckhoff DE, Tector M, Tector AJ.

Transplantation. 2017 Apr;101(4):e86-e92. doi: 10.1097/TP.0000000000001646. Erratum in: Transplantation. 2018 Feb;102(2):e88.

PMID:
28114170
17.

A SEER Database Analysis of the Survival Advantage of Transarterial Chemoembolization for Hepatocellular Carcinoma: An Underutilized Therapy.

Gray SH, White JA, Li P, Kilgore ML, Redden DT, Abdel Aal AK, Simpson HN, McGuire B, Eckhoff DE, Dubay DA.

J Vasc Interv Radiol. 2017 Feb;28(2):231-237.e2. doi: 10.1016/j.jvir.2016.09.022. Epub 2016 Dec 9.

18.

Insurance Type and Solid Organ Transplantation Outcomes: A Historical Perspective on How Medicaid Expansion Might Impact Transplantation Outcomes.

DuBay DA, MacLennan PA, Reed RD, Shelton BA, Redden DT, Fouad M, Martin MY, Gray SH, White JA, Eckhoff DE, Locke JE.

J Am Coll Surg. 2016 Oct;223(4):611-620.e4. doi: 10.1016/j.jamcollsurg.2016.07.004. Epub 2016 Jul 25.

19.

Does the Degree of Hepatocellular Carcinoma Tumor Necrosis following Transarterial Chemoembolization Impact Patient Survival?

Haywood N, Gennaro K, Obert J, Sauer PF Jr, Redden DT, Zarzour J, Smith JK, Bolus D, Saddekni S, Aal AK, Gray S, White J, Eckhoff DE, DuBay DA.

J Oncol. 2016;2016:4692139. doi: 10.1155/2016/4692139. Epub 2016 Feb 2.

20.

The impact of proposed changes in liver allocation policy on cold ischemia times and organ transportation costs.

DuBay DA, MacLennan PA, Reed RD, Fouad M, Martin M, Meeks CB, Taylor G, Kilgore ML, Tankersley M, Gray SH, White JA, Eckhoff DE, Locke JE.

Am J Transplant. 2015 Feb;15(2):541-6. doi: 10.1111/ajt.12981.

21.

Risk Factors Associated with Reoperation for Bleeding following Liver Transplantation.

Thompson MA, Redden DT, Glueckert L, Smith AB, Crawford JH, Jones KA, Eckhoff DE, Gray SH, White JA, Bloomer J, DuBay DA.

HPB Surg. 2014;2014:816246. doi: 10.1155/2014/816246. Epub 2014 Nov 20.

22.

Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of ≥ 3 cm.

Jacob R, Turley F, Redden DT, Saddekni S, Aal AK, Keene K, Yang E, Zarzour J, Bolus D, Smith JK, Gray S, White J, Eckhoff DE, DuBay DA.

HPB (Oxford). 2015 Feb;17(2):140-9. doi: 10.1111/hpb.12331. Epub 2014 Sep 4.

23.

Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinoma.

White JA, Redden DT, Bryant MK, Dorn D, Saddekni S, Abdel Aal AK, Zarzour J, Bolus D, Smith JK, Gray S, Eckhoff DE, DuBay DA.

HPB (Oxford). 2014 Dec;16(12):1095-101. doi: 10.1111/hpb.12313. Epub 2014 Aug 26.

24.

Chemoembolization outcomes for hepatocellular carcinoma in cirrhotic patients with compromised liver function.

Dorn DP, Bryant MK, Zarzour J, Smith JK, Redden DT, Saddekni S, Abdel Aal AK, Gray S, White J, Eckhoff DE, DuBay DA.

HPB (Oxford). 2014 Jul;16(7):648-55.

25.

Hemorrhagic shock one month following uncomplicated liver transplantation.

Ren Z, Litovsky S, Eckhoff DE, DuBay DA.

Am J Transplant. 2014 Jun;14(6):1461-3. doi: 10.1111/ajt.12551. No abstract available.

26.

A randomized clinical trial testing the anti-inflammatory effects of preemptive inhaled nitric oxide in human liver transplantation.

Lang JD Jr, Smith AB, Brandon A, Bradley KM, Liu Y, Li W, Crowe DR, Jhala NC, Cross RC, Frenette L, Martay K, Vater YL, Vitin AA, Dembo GA, Dubay DA, Bynon JS, Szychowski JM, Reyes JD, Halldorson JB, Rayhill SC, Dick AA, Bakthavatsalam R, Brandenberger J, Broeckel-Elrod JA, Sissons-Ross L, Jordan T, Chen LY, Siriussawakul A, Eckhoff DE, Patel RP.

PLoS One. 2014 Feb 12;9(2):e86053. doi: 10.1371/journal.pone.0086053. eCollection 2014.

27.

Resource utilization associated with procurement of transplantable organs from donors that do not meet OPTN eligible death criteria.

DuBay DA, Redden DT, Bryant MK, Dorn DP, Fouad MN, Gray SH, White JA, Locke JE, Meeks CB, Taylor GC, Kilgore ML, Eckhoff DE.

Transplantation. 2014 May 27;97(10):1043-8. doi: 10.1097/01.TP.0000441093.32217.cb.

28.

Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients.

Alloway RR, Eckhoff DE, Washburn WK, Teperman LW.

Liver Transpl. 2014 May;20(5):564-75. doi: 10.1002/lt.23844. Epub 2014 Mar 26.

29.

Do trained specialists solicit familial authorization at equal frequency, regardless of deceased donor characteristics?

Dubay DA, Redden DT, Haque A, Gray SH, Fouad M, Kohler C, Taylor G, Eckhoff DE.

Prog Transplant. 2013 Sep;23(3):290-6. doi: 10.7182/pit2013406.

30.

Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolization.

Bryant MK, Dorn DP, Zarzour J, Smith JK, Redden DT, Saddekni S, Abdel Aal AK, Gray SH, Eckhoff DE, Dubay DA.

HPB (Oxford). 2014 Apr;16(4):327-35. doi: 10.1111/hpb.12149. Epub 2013 Aug 26.

31.

What liver transplant outcomes can be expected in the uninsured who become insured via the Affordable Care Act?

Glueckert LN, Redden D, Thompson MA, Haque A, Gray SH, Locke J, Eckhoff DE, Fouad M, DuBay DA.

Am J Transplant. 2013 Jun;13(6):1533-40. doi: 10.1111/ajt.12244. Epub 2013 May 9.

32.

Sodium nitrite protects against kidney injury induced by brain death and improves post-transplant function.

Kelpke SS, Chen B, Bradley KM, Teng X, Chumley P, Brandon A, Yancey B, Moore B, Head H, Viera L, Thompson JA, Crossman DK, Bray MS, Eckhoff DE, Agarwal A, Patel RP.

Kidney Int. 2012 Aug;82(3):304-13. doi: 10.1038/ki.2012.116. Epub 2012 Apr 25.

33.

Inflammation anergy in human intestinal macrophages is due to Smad-induced IkappaBalpha expression and NF-kappaB inactivation.

Smythies LE, Shen R, Bimczok D, Novak L, Clements RH, Eckhoff DE, Bouchard P, George MD, Hu WK, Dandekar S, Smith PD.

J Biol Chem. 2010 Jun 18;285(25):19593-604. doi: 10.1074/jbc.M109.069955. Epub 2010 Apr 13.

34.

Human primary gastric dendritic cells induce a Th1 response to H. pylori.

Bimczok D, Clements RH, Waites KB, Novak L, Eckhoff DE, Mannon PJ, Smith PD, Smythies LE.

Mucosal Immunol. 2010 May;3(3):260-9. doi: 10.1038/mi.2010.10. Epub 2010 Mar 17.

35.

Radiofrequency ablation for unresectable tumors of the liver.

Howard JH, Tzeng CW, Smith JK, Eckhoff DE, Bynon JS, Wang T, Arnoletti JP, Heslin MJ.

Am Surg. 2008 Jul;74(7):594-600; discussion 600-1.

PMID:
18646476
36.

Selection of candidates for islet xenotransplantation.

Eckhoff DE.

Xenotransplantation. 2008 Mar-Apr;15(2):102-3. doi: 10.1111/j.1399-3089.2008.00462.x. No abstract available.

PMID:
18447879
37.

Retraction: Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control.

Thomas JM, Contreras JL, Wang PX, Eckhoff DE, Asiedu C, Hubbard WJ, Cartner S, Thomas FT, Robbin ML, Nadler S, Cook WJ, Sharff J, Neville DM Jr, Shiloach J.

Transplantation. 2008 Mar 27;85(6):920. doi: 10.1097/TP.0b013e318172dbe0. No abstract available.

PMID:
18360278
38.

Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study.

Klintmalm GB, Washburn WK, Rudich SM, Heffron TG, Teperman LW, Fasola C, Eckhoff DE, Netto GJ, Katz E.

Liver Transpl. 2007 Nov;13(11):1521-31.

39.

Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation.

Lang JD Jr, Teng X, Chumley P, Crawford JH, Isbell TS, Chacko BK, Liu Y, Jhala N, Crowe DR, Smith AB, Cross RC, Frenette L, Kelley EE, Wilhite DW, Hall CR, Page GP, Fallon MB, Bynon JS, Eckhoff DE, Patel RP.

J Clin Invest. 2007 Sep;117(9):2583-91.

40.

Racial disparities in renal allograft survival: a public health issue?

Eckhoff DE, Young CJ, Gaston RS, Fineman SW, Deierhoi MH, Foushee MT, Brown RN, Diethelm AG.

J Am Coll Surg. 2007 May;204(5):894-902; discussion 902-3.

PMID:
17481506
41.

Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer.

Stoff-Khalili MA, Rivera AA, Stoff A, Michael Mathis J, Rocconi RP, Matthews QL, Numnum MT, Herrmann I, Dall P, Eckhoff DE, Douglas JT, Siegal GP, Zhu ZB, Curiel DT.

Int J Cancer. 2007 Feb 15;120(4):935-41.

42.

Retraction: Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy.

Thomas JM, Eckhoff DE, Contreras JL, Thomas FT, Neville DM Jr, Lobashevsky A, Hubbard WJ, Cook WJ.

Transplantation. 2006 Aug 27;82(4):577. No abstract available.

PMID:
16926605
43.

Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation.

McGuire BM, Julian BA, Bynon JS Jr, Cook WJ, King SJ, Curtis JJ, Accortt NA, Eckhoff DE.

Ann Intern Med. 2006 May 16;144(10):735-41.

PMID:
16702589
44.

[Liver transplantation of living donor adult-to-adult].

Vilatobá M, Eckhoff DE, Contreras JL.

Rev Invest Clin. 2005 Mar-Apr;57(2):252-61. Review. Spanish.

PMID:
16524066
45.

[Recipient selection for liver transplantation].

Vilatobá M, Eckhoff DE, Contreras JL.

Rev Invest Clin. 2005 Mar-Apr;57(2):244-51. Review. Spanish.

PMID:
16524065
46.

Sodium 4-phenylbutyrate protects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum-stress mediated apoptosis.

Vilatoba M, Eckstein C, Bilbao G, Smyth CA, Jenkins S, Thompson JA, Eckhoff DE, Contreras JL.

Surgery. 2005 Aug;138(2):342-51.

PMID:
16153446
47.

17beta-estradiol differentially activates mitogen-activated protein-kinases and improves survival following reperfusion injury of reduced-size liver in mice.

Vilatoba M, Eckstein C, Bilbao G, Frennete L, Eckhoff DE, Contreras JL.

Transplant Proc. 2005 Jan-Feb;37(1):399-403.

PMID:
15808658
48.

Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death.

Contreras JL, Eckstein C, Smyth CA, Bilbao G, Vilatoba M, Ringland SE, Young C, Thompson JA, Fernández JA, Griffin JH, Eckhoff DE.

Diabetes. 2004 Nov;53(11):2804-14.

49.

Two-dose daclizumab induction therapy in 209 liver transplants: a single-center analysis.

Sellers MT, McGuire BM, Haustein SV, Bynon JS, Hunt SL, Eckhoff DE.

Transplantation. 2004 Oct 27;78(8):1212-7.

PMID:
15502722
50.

A novel approach to xenotransplantation combining surface engineering and genetic modification of isolated adult porcine islets.

Contreras JL, Xie D, Mays J, Smyth CA, Eckstein C, Rahemtulla FG, Young CJ, Anthony Thompson J, Bilbao G, Curiel DT, Eckhoff DE.

Surgery. 2004 Sep;136(3):537-47.

PMID:
15349100

Supplemental Content

Loading ...
Support Center